<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35298894</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2468-2667</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>The Lancet. Public health</Title><ISOAbbreviation>Lancet Public Health</ISOAbbreviation></Journal><ArticleTitle>Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study.</ArticleTitle><Pagination><StartPage>e406</StartPage><EndPage>e416</EndPage><MedlinePgn>e406-e416</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2468-2667(22)00042-1</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2468-2667(22)00042-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long-term mental and physical health consequences of COVID-19 (long COVID) are a persistent public health concern. Little is still known about the long-term mental health of non-hospitalised patients with COVID-19 with varying illness severities. Our aim was to assess the prevalence of adverse mental health symptoms among individuals diagnosed with COVID-19 in the general population by acute infection severity up to 16 months after diagnosis.</AbstractText><AbstractText Label="METHODS">This observational follow-up study included seven prospectively planned cohorts across six countries (Denmark, Estonia, Iceland, Norway, Sweden, and the UK). Participants were recruited from March 27, 2020, to Aug 13, 2021. Individuals aged 18 years or older were eligible to participate. In a cross-sectional analysis, we contrasted symptom prevalence of depression, anxiety, COVID-19-related distress, and poor sleep quality (screened with validated mental health instruments) among individuals with and without a diagnosis of COVID-19 at entry, 0-16 months from diagnosis. In a cohort analysis, we further used repeated measures to estimate the change in mental health symptoms before and after COVID-19 diagnosis.</AbstractText><AbstractText Label="FINDINGS">The analytical cohort consisted of 247&#x2008;249 individuals, 9979 (4&#xb7;0%) of whom were diagnosed with COVID-19 during the study period. Mean follow-up was 5&#xb7;65 months (SD 4&#xb7;26). Participants diagnosed with COVID-19 presented overall with a higher prevalence of symptoms of depression (prevalence ratio [PR] 1&#xb7;18 [95% CI 1&#xb7;03-1&#xb7;36]) and poorer sleep quality (1&#xb7;13 [1&#xb7;03-1&#xb7;24]) but not symptoms of anxiety (0&#xb7;97 [0&#xb7;91-1&#xb7;03]) or COVID-19-related distress (1&#xb7;05 [0&#xb7;93-1&#xb7;20]) compared with individuals without a COVID-19 diagnosis. Although the prevalence of depression and COVID-19-related distress attenuated with time, individuals diagnosed with COVID-19 but never bedridden due to their illness were consistently at lower risk of depression (PR 0&#xb7;83 [95% CI 0&#xb7;75-0&#xb7;91]) and anxiety (0&#xb7;77 [0&#xb7;63-0&#xb7;94]) than those not diagnosed with COVID-19, whereas patients who were bedridden for more than 7 days were persistently at higher risk of symptoms of depression (PR 1&#xb7;61 [95% CI 1&#xb7;27-2&#xb7;05]) and anxiety (1&#xb7;43 [1&#xb7;26-1&#xb7;63]) than those not diagnosed throughout the study period.</AbstractText><AbstractText Label="INTERPRETATION">Severe acute COVID-19 illness-indicated by extended time bedridden-is associated with long-term mental morbidity among recovering individuals in the general population. These findings call for increased vigilance of adverse mental health development among patients with a severe acute disease phase of COVID-19.</AbstractText><AbstractText Label="FUNDING">Nordforsk, Horizon2020, Wellcome Trust, and Estonian Research Council.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Magn&#xfa;sd&#xf3;ttir</LastName><ForeName>Ingibj&#xf6;rg</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovik</LastName><ForeName>Anik&#xf3;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unnarsd&#xf3;ttir</LastName><ForeName>Anna B&#xe1;ra</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCartney</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ask</LastName><ForeName>Helga</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf5;iv</LastName><ForeName>Kadri</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Estonian Genome Centre, Institute of Genomics, University of Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christoffersen</LastName><ForeName>Lea Arregui Nordahl</ForeName><Initials>LAN</Initials><AffiliationInfo><Affiliation>Institute of Biological Psychiatry, Mental Health Services Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Sverre Urnes</ForeName><Initials>SU</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway; Modum Bad Psychiatric Center, Vikersund, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauksd&#xf3;ttir</LastName><ForeName>Arna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fawns-Ritchie</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK; Department of Psychology, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helenius</LastName><ForeName>Dorte</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Biological Psychiatry, Mental Health Services Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Hij&#xf3;n</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway; NORMENT Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebrahimi</LastName><ForeName>Omid V</ForeName><Initials>OV</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway; Modum Bad Psychiatric Center, Vikersund, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffart</LastName><ForeName>Asle</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway; Modum Bad Psychiatric Center, Vikersund, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porteous</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakobsd&#xf3;ttir</LastName><ForeName>J&#xf3;hanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehto</LastName><ForeName>Kelli</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Estonian Genome Centre, Institute of Genomics, University of Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreassen</LastName><ForeName>Ole A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>NORMENT Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Ole B V</ForeName><Initials>OBV</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Zealand University Hospital, Koege, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aspelund</LastName><ForeName>Thor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland; The Icelandic Heart Association, Kopavogur, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdimarsd&#xf3;ttir</LastName><ForeName>Unnur Anna</ForeName><Initials>UA</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland; Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA. Electronic address: unnurav@hi.is.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>COVIDMENT Collaboration</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CZD/16/6</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>216767/Z/19/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Public Health</MedlineTA><NlmUniqueID>101699003</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests OAA has received a grant to their institution from Nordforsk and Research Council of Norway for the present manuscript. OAA has also received a grant to the institution for an entity other than the present manuscript from South East Norway Health Authority, KG Jebsen Stiftelsen, and National Institutes of Health, EU. OAA has received royalties for a textbook in psychiatry, consulting fees from HealthLytix and Milken Institute, payment for lectures from Sunovion and Lundbeck, and payment for expert testimony from the Norwegian Court. Outside of this work, OAA has a patent for a devise for nasal delivery. OAA has participated at his institution on boards for local principal investigator Clinical Trial Janssen, local principal investigator Clinical Trial MAPS, and local principal investigator Clinical Trial Boehringer. UAV has received grants for the current work from Nordforsk and Horizon2020 as well as grants outside the current work from the Icelandic Research Fund, Swedish Research Council, Swedish Cancer Society, and the European Research Council. All other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Magn&#xfa;sd&#xf3;ttir</LastName><ForeName>Ingibj&#xf6;rg</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lovik</LastName><ForeName>Anik&#xf3;</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Unnarsd&#xf3;ttir</LastName><ForeName>Anna B&#xe1;ra</ForeName><Initials>AB</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCartney</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ask</LastName><ForeName>Helga</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>K&#xf5;iv</LastName><ForeName>Kadri</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nordahl Christoffersen</LastName><ForeName>Lea Arregui</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Sverre Urnes</ForeName><Initials>SU</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIntosh</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>K&#xe4;hler</LastName><ForeName>Anna K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campbell</LastName><ForeName>Archie</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hauksd&#xf3;ttir</LastName><ForeName>Arna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fawns-Ritchie</LastName><ForeName>Chloe</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erikstrup</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Helenius</LastName><ForeName>Dorte</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Altschul</LastName><ForeName>Drew</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thordardottir</LastName><ForeName>Edda Bjork</ForeName><Initials>EB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ey&#xfe;&#xf3;rsson</LastName><ForeName>El&#xed;as</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frans</LastName><ForeName>Emma M</ForeName><Initials>EM</Initials></Investigator><Investigator ValidYN="Y"><LastName>T&#xf3;masson</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>J&#xf3;nsd&#xf3;ttir</LastName><ForeName>Harpa Lind</ForeName><Initials>HL</Initials></Investigator><Investigator ValidYN="Y"><LastName>R&#xfa;narsd&#xf3;ttir</LastName><ForeName>Harpa</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hjalgrim</LastName><ForeName>Henrik</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Har&#xf5;ard&#xf3;ttir</LastName><ForeName>Hr&#xf6;nn</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez-Hij&#xf3;n</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Banasik</LastName><ForeName>Karina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dinh</LastName><ForeName>Khoa Manh</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lu</LastName><ForeName>Li</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milani</LastName><ForeName>Lili</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trogstad</LastName><ForeName>Lill</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Didriksen</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ebrahimi</LastName><ForeName>Omid V</ForeName><Initials>OV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Patrick F</ForeName><Initials>PF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magnus</LastName><ForeName>Per Minor</ForeName><Initials>PM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shen</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nesv&#xe5;g</LastName><ForeName>Ragnar</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>M&#xe4;gi</LastName><ForeName>Reedik</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>P&#xe1;lsson</LastName><ForeName>Run&#xf3;lfur</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ostrowski</LastName><ForeName>Sisse Rye</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Werge</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoffart</LastName><ForeName>Asle</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porteous</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fang</LastName><ForeName>Fang</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jakobsd&#xf3;ttir</LastName><ForeName>J&#xf3;hanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lehto</LastName><ForeName>Kelli</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andreassen</LastName><ForeName>Ole A</ForeName><Initials>OA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Ole B V</ForeName><Initials>OBV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aspelund</LastName><ForeName>Thor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valdimarsd&#xf3;ttir</LastName><ForeName>Unnur Anna</ForeName><Initials>UA</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>20</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35298894</ArticleId><ArticleId IdType="pmc">PMC8920517</ArticleId><ArticleId IdType="doi">10.1016/S2468-2667(22)00042-1</ArticleId><ArticleId IdType="pii">S2468-2667(22)00042-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2008;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong F, Liu HL, Dai N, Yang M, Liu JP. A living systematic review of the psychological problems in people suffering from COVID-19. J Affect Disord. 2021;292:172&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169237</ArticleId><ArticleId IdType="pubmed">34126309</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Zhou F, Hou W, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486:90&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675607</ArticleId><ArticleId IdType="pubmed">33009668</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Jia X, Shi H, et al. Prevalence of mental health problems during the COVID-19 pandemic: a systematic review and meta-analysis. J Affect Disord. 2021;281:91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7710473</ArticleId><ArticleId IdType="pubmed">33310451</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto I, Navas JF, V&#xe1;zquez C. The quality of research on mental health related to the COVID-19 pandemic: a note of caution after a systematic review. Brain Behav Immun Health. 2020;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395946</ArticleId><ArticleId IdType="pubmed">32835299</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho PMM, Moreira MM, de Oliveira MNA, Landim JMM, Neto MLR. The psychiatric impact of the novel coronavirus outbreak. Psychiatry Res. 2020;286</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7133679</ArticleId><ArticleId IdType="pubmed">32146248</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158942</ArticleId><ArticleId IdType="pubmed">32112714</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MM, Tasnim S, Sultana A, et al. Epidemiology of mental health problems in COVID-19: a review. F1000 Res. 2020;9:636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7549174</ArticleId><ArticleId IdType="pubmed">33093946</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Pan R, Wan X, et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav Immun. 2020;87:40&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153528</ArticleId><ArticleId IdType="pubmed">32298802</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Chen W, Hu Y, et al. Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis. Lancet Healthy Longev. 2020;1:e69&#x2013;e79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832159</ArticleId><ArticleId IdType="pubmed">33521769</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27:28&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Unnarsd&#xf3;ttir AB, Lovik A, Fawns-Ritchie C, et al. Cohort profile: COVIDMENT: COVID-19 cohorts on mental health across six nations. Int J Epidemiol. 2021 doi: 10.1093/ije/dyab234. published online Nov 20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab234</ArticleId><ArticleId IdType="pmc">PMC8690101</ArticleId><ArticleId IdType="pubmed">35020900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Aluoja A, Shlik J, Vasar V, Luuk K, Leinsalu M. Development and psychometric properties of the Emotional State Questionnaire, a self-report questionnaire for depression and anxiety. Nord J Psychiatry. 1999;53:443&#x2013;449.</Citation></Reference><Reference><Citation>&#xd6;&#xf6;pik P, Aluoja A, Kalda R, Maaroos H-I. Screening for depression in primary care. Fam Pract. 2006;23:693&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pubmed">17035287</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JB, L&#xf6;we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins A, Bovin MJ, Smolenski DJ, et al. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample. J Gen Intern Med. 2016;31:1206&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5023594</ArticleId><ArticleId IdType="pubmed">27170304</ArticleId></ArticleIdList></Reference><Reference><Citation>Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Annual convention of the International Society for Traumatic Stress Studies; January, 1993: San Antonio, TX.</Citation></Reference><Reference><Citation>Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: a meta-analysis. Nicotine Tob Res. 2020;22:1653&#x2013;1656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239135</ArticleId><ArticleId IdType="pubmed">32399563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wootton RE, Richmond RC, Stuijfzand BG, et al. Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study. Psychol Med. 2020;50:2435&#x2013;2443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610182</ArticleId><ArticleId IdType="pubmed">31689377</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon GE, Von Korff M, Saunders K, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63:824&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1913935</ArticleId><ArticleId IdType="pubmed">16818872</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Qian L, Shi J, Franklin M. Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification. BMC Med Res Methodol. 2018;18:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6013902</ArticleId><ArticleId IdType="pubmed">29929477</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">15033648</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22:661&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">22072596</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1&#x2013;48.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH-B, Wing Y-K, Yu MW-M, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169:2142&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HY, Park WB, Lee SH, et al. Posttraumatic stress disorder and depression of survivors 12&#x2008;months after the outbreak of Middle East respiratory syndrome in South Korea. BMC Public Health. 2020;20:605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224724</ArticleId><ArticleId IdType="pubmed">32410603</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen PA, Olsen RJ, Long SW, et al. Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the omicron variant of SARS-CoV-2 in Houston, Texas. Am J Pathol. 2022 doi: 10.1016/j.ajpath.2022.01.007. published online Feb 3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2022.01.007</ArticleId><ArticleId IdType="pmc">PMC8812084</ArticleId><ArticleId IdType="pubmed">35123975</ArticleId></ArticleIdList></Reference><Reference><Citation>Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392963</ArticleId><ArticleId IdType="pubmed">16316783</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919277</ArticleId><ArticleId IdType="pubmed">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Lwin MN, Serhal L, Holroyd C, Edwards CJ. Rheumatoid arthritis: the impact of mental health on disease: a narrative review. Rheumatol Ther. 2020;7:457&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410879</ArticleId><ArticleId IdType="pubmed">32535834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>